Enter your login e-mail to the account
Search
- Promoting prevention and treatment of cardiovascular disease through nutrition supplements
doc. MUDr. Štefan Farský, CSc., FESC
(5/2012, Review articles ) - Drug-induced myopathy with cholesterol-lowering and triacylglycerol-lowering agents
doc. MUDr. Peter Špalek, CSc., MUDr. Denis Richter
(1/2010, Interdisciplinary consilium ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(10/2009, Topic of the year )
- Statins and myopathy
prof. MUDr. Zdeněk Ambler, DrSc. †
(6/2013, Review articles ) - Toxic myopathies
doc. MUDr. Edvard Ehler, CSc. , Prof. MUDr. Josef Zámečník, Ph.D.
(6/2016, Review articles ) - Effects of drugs on neuromuscular junction
MUDr. Stanislav Voháňka, CSc., MBA
(1/2017, Main topic ) - Statins and neuroprotective effects
prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN, PharmDr. Aleš Dvořák, MBA
(1/2021, Review articles ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic ) - Polymyositis
prof. MUDr. Jiří Vencovský, DrSc.
(5/2014, From the boundary of neurology )
- Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy )
- Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(4/2010, Drugs & drug classes )